1.43
1.43 (0%)
As of Jun 27, 2024
Tracon Pharmaceuticals, Inc. [TCON]
Source:
Company Overview
Tracon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing our cost efficient, contract research organization independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 550-0780 |
| Industry | manufacturing |
| CEO | Charles P. Theuer, M.D., Ph.D. |
| Website | www.traconpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-2.9 |
| Net Income | $-2.8 |
| Net Cash | $-2.3 |
Profit Ratios
| Gross Margin | $0.1 |
| Operating Margin | -5,294.6 |
| Profit as % of Revenues | -1.9% |
| Profit as % of Assets | -76.2% |
| Profit as % of Stockholder Equity | 91.9% |
Management Effectiveness
| Return on Equity | 91.9% |
| Return on Assets | -38.4% |
| Turnover Ratio | 1.5% |
| EBITA | $-2.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $7.4 |
| Total Liabilities | $10.5 |
| Operating Cash Flow | $-5.3 |
| Investing Cash Flow | |
| Financing Cash Flow | $3 |
